UL - Cannabis Industry's Capital Crunch: Why It Needs More Funds Than Other Industries Will Fed Legalization Change This? | Benzinga
Recent research conducted by Viridian Capital Advisors reveals that the cannabis sector requires more capital as compared to other similar industries.
The findings offer a unique perspective into the challenges the cannabis industry faces, especially considering the potential for federal legalization and the subsequent acquisition of interest from other sectors.
Scott Greiper, president & founder of Viridian Capital Advisors, will be a featured speaker at the upcoming Benzinga Cannabis Capital Conference in Chicago from September 27-28. Expect him to delve into this crucial topic during his presentation.
Related Content: Federal Marijuana Legalization Is Doable And Urgently Needed, Says Cannabis Coalition's New White Paper
Breakdown of Companies Surveyed
For this research, Viridian chose to evaluate the capital needs of the cannabis industry against four potential acquirer sectors in the event of federal legalization.
Here's a breakdown:
- Cannabis: Includes nine multistate operators boasting market caps exceeding $100 million.
- Tobacco: Comprises British American Tobacco (NYSE: BTI), Altria Group Inc (NYSE: MO), Philip Morris International (NYSE: PM), and Japan Tobacco (NYSE: JAPAF).
- Alcoholic beverages: Encompasses ABEV (NYSE: ABEV), Brown-Forman (NYSE: BF/B), Constellation Brands (NYSE: STZ), Diageo (NYSE: DEO), and Molson Coors (NYSE: TAP).
- Pharmaceuticals: Features giants like Johnson ...